Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy

Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy

The in vivoanticancer efficacy of nanoparticle-mediated drug delivery depends on the association between the drug and its carrier. Here, the authors use FRET to show that the drug hydrophobicity, and miscibility with the carrier, influence nanoparticle accumulation in murine tumour models.

Guardado en:
Detalles Bibliográficos
Autores principales: Yiming Zhao, François Fay, Sjoerd Hak, Jose Manuel Perez-Aguilar, Brenda L. Sanchez-Gaytan, Brandon Goode, Raphaël Duivenvoorden, Catharina de Lange Davies, Astrid Bjørkøy, Harel Weinstein, Zahi A. Fayad, Carlos Pérez-Medina, Willem J. M. Mulder
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/d90fceee65ae4c4ca9f5fa1e73acfa06
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d90fceee65ae4c4ca9f5fa1e73acfa06

Ejemplares similares